Prostatype Genomics ABPROGEN 
$0.00-2.63%24h
-2.63%24h
Global rank
Market cap$335.52K
Change 7d42.31%
YTD Performance-80.53%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Prostatype Genomics AB (PROGEN)
As of November 2024, Prostatype Genomics AB has a market cap of $335.52K. This makes Prostatype Genomics AB the world's th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Prostatype Genomics AB from 2020 to 2024
-
Value:-
Market cap history of Prostatype Genomics AB from 2020 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $881.41K | -48.84% |
| 2023 | $1.72M | -95.52% |
| 2022 | $38.45M | -76.29% |
| 2021 | $162.14M | -37.48% |
| 2020 | $259.35M | - |
PROGEN Market Cap Today is $335.52K -2.63% - 1 Nov 2024
View largest stocks by market cap 
